The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A01 | Stomatological preparations | |
| 3 | A01A | Stomatological preparations | |
| 4 | A01AA | Caries prophylactic agents |
| Code | Title | |
|---|---|---|
| A01AA01 | Sodium fluoride | |
| A01AA02 | Sodium monofluorophosphate | |
| A01AA03 | Olaflur | |
| A01AA04 | Stannous fluoride | |
| A01AA30 | Combinations | |
| A01AA51 | Sodium fluoride, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Sodium fluoride |
Sodium fluoride is indicated for the prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries). The primary mode of the caries preventative action of fluoride is post-eruptive, i.e topical action. Systemic fluoride supplements are believed also to act mainly topically (i.e during ingestion, via saliva). |
